The various comorbidities of Major Depressive Disorder (MDD) adversely affect patients’ quality of life. MDD frequently occurs alongside substance-related and anxiety disorders, as well as a host of other physical conditions such as type 2 diabetes. This slide deck includes graphic illustrations of a retrospective analysis of patient data performed to compare the prevalence of chronic conditions in patients with MDD.

This slide deck has been developed in collaboration with the former Lundbeck International Neuroscience Foundation.

Index for
slide deck

Introduction

Comorbidity
Comorbidity

A retrospective analysis of patient data was performed to compare the prevalence of chronic conditions in patients with MDD. Of the total population studied, roughly one in ten had depression.

file_download Download slide in HQ
Prevalence of chronic conditions in patients with MDD
Prevalence of chronic conditions in patients with MDD

In this study, data from the 2007 and 2009 releases of the Medical Expenditure Panel Survey (MEPS) were used.[Bhattacharya et al., 2014] The MEPS is a nationally representative annual survey of households representing the US non-institutionalised civilian population.[Bhat…

file_download Download slide in HQ
Prevalence of MDD in patients with chronic conditions
Prevalence of MDD in patients with chronic conditions

The analysis discussed here concludes that there exists a bidirectional relationship between depression and chronic illnesses.[Voinov et al., 2013]

Reference:
Voinov B, Richie WD, Bailey RK. Depression and chronic diseases: it is time for a synergistic mental health and p…

file_download Download slide in HQ
Depression adds to the burden of chronic conditions
Depression adds to the burden of chronic conditions

The WHO (World Health Organization) World Health Survey studied >240, 000 adults, aged ≥18 years, across 60 countries.[Moussavi et al., 2007] An average of 9.3–23.0% of participants with one or more chronic physical disease also had comorbid depression.[Moussavi et al., 2…

file_download Download slide in HQ
The effect of comorbidities on patients’ quality of life
The effect of comorbidities on patients’ quality of life

The various comorbidities of MDD (psychiatric and physical) adversely affect the quality of life of the patient.[IsHak et al., 2014; IsHak et al., 2018; Zhou et al., 2017] This emphasises the point that attending physicians need to be alive to the potential of the various…

file_download Download slide in HQ

Neuropsychiatric comorbidities

Neuropsychiatric comorbidities
Neuropsychiatric comorbidities
file_download Download slide in HQ
Psychiatric comorbidities of MDD
Psychiatric comorbidities of MDD

The study by Thaipisuttikul and colleagues was a cross-sectional study, conducted between October 2012 and January 2014.[Thaipisuttikul et al., 2014] In total, 190 patients with MDD, as confirmed by the Mini International Neuropsychiatric Interview (MINI), were included.[…

file_download Download slide in HQ
Anxiety
Anxiety

The Patient Health Questionnaire is a self-administered tool of 2 (PHQ-2) or 9 (PHQ-9) items.[Kroenke et al., 2001; Spitzer et al., 1999] The PHQ-9 establishes the clinical diagnosis of depression and can additionally be used to track the severity of symptoms over time.[K…

file_download Download slide in HQ
Obsessive–compulsive disorder (OCD)
Obsessive–compulsive disorder (OCD)

Obsessive-compulsive disorder (OCD) is associated with reduced quality of life, and functional impairments.[APA, 2013, pg. 240] It is defined as:[APA, 2013, pg. 237] obsession; recurrent and persistent thoughts, urges, or images, that are experienced as unwanted or intrus…

file_download Download slide in HQ
Post-traumatic stress disorder (PTSD)
Post-traumatic stress disorder (PTSD)

The essential feature of PTSD is the development of a certain set of symptoms after exposure to a traumatic event; the symptoms include fear-based re-experiencing of the traumatic event, but can also include anhedonia, and dysphoric mood states.[APA, 2013, pg. 274] Theref…

file_download Download slide in HQ
Attention deficit hyperactivity disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD)

The essential feature of ADHD is a persistent pattern of inattention and/or hyperactivity that interferes with functioning or development.[APA, 2013, pg. 61] For example, wandering off task, or difficulty sustaining focus, and excessive motor activity, or fidgeting, or ta…

file_download Download slide in HQ
Schizophrenia
Schizophrenia

The essential feature of schizophrenia is the presence of hallucinations, delusions, disorganised speech or behaviour, or of negative symptoms.[APA, 2013, pg. 100] As noted on the slide, some of the diagnostic criteria for schizophrenia overlap with those for MDD, particu…

file_download Download slide in HQ
Substance-use disorder
Substance-use disorder

Substance-use disorders are a group of cognitive, behavioural, and physiological symptoms indicating that the individual continues to use a substance despite problems related to the use of that substance.[APA, 2013, pg. 483] Substances can include alcohol, cannabis, hallu…

file_download Download slide in HQ
Neurological disorders and MDD
Neurological disorders and MDD

See Slide deck #3 of this series – ‘Neurobiology and aetiology’ to read more about the potential shared pathways underlying MDD and other neurological disorders. Disentangling the various comorbidities of MDD is a herculean challenge, because many conditions are interrela…

file_download Download slide in HQ
Alzheimer’s disease (AD) and MDD
Alzheimer’s disease (AD) and MDD

Whether or not, and to what extent, depression is a risk factor for, or a constituent part of the prodrome of, dementia, is still a contentious issue.[Cha et al., 2014; Mirza et al., 2014] One study followed >4, 300 non-demented individuals for 13.7 years, and tracked the…

file_download Download slide in HQ

Related content

grid_view Slide Deck A short summary of what we know todaya on classical psychedelics for the treatment of depression
Psychedelics fact sheet

This slide deck summarizes the current knowledge surrounding the use of psychedelics for the treatment of depression. Specifically, our focus centers on serotonergic psychedelics, commonly referred to as classical psychedelics. These psychedelics primarily function as agonists or partial agonists at the serotonin 2A receptor (5-HT2A receptor).

14.12.2023 Depression
image Image A New Approach To Tackle The Worldwide Impact Of Depression
A New Approach To Tackle The Worldwide Impact Of Depression

The infographic shows a 27% increase in depression cases due to COVID-19, affecting 280 million people worldwide.

21.11.2023 Depression
Polygenic Scores in Psychiatry: The example of Depression play_circle Video play_circle
Polygenic Scores in Psychiatry: The example of Depression

Dr. Jasmina Mallet highlights the latest research in psychiatric genetics, emphasizing the role of Polygenic Risk Scores (PRS) in psychiatry.

14.11.2023 Depression